Health Minister MP this week visited the
Medicines and Healthcare products Regulatory Agency (MHRA) to see
first-hand how its scientists ensure NHS patients receive the
latest medical innovations safely and in the shortest time
possible.
As part of British Science Week and NHS Healthcare Science Week,
the visit highlighted the MHRA's role in driving life sciences
innovation - helping UK patients benefit from cutting-edge
technologies, from mRNA vaccines to advanced cancer diagnostics.
During the visit, Minister Smyth met with MHRA scientists and
regulatory experts to hear how their work is helping the NHS move
towards earlier diagnosis and prevention. This includes making
sure the annual flu vaccine is as effective as possible, setting
safety standards for genomic cancer testing, and enabling rapid
access to new treatments.
The Minister toured MHRA biologics laboratories, where scientists
rigorously test biological medicines, including vaccines, to
ensure they are effective and acceptably safe for patients. She
also heard how the MHRA works with industry and healthcare
partners to keep vital medicines available, so patients can
access the treatments they need without delay.
The MHRA's expertise has global impact, with its scientific and
regulatory leadership helping to shape international standards
and ensure that innovations benefit patients worldwide.
Health Minister MP said:
“The MHRA's scientists are making a real difference by ensuring
NHS patients can benefit from the latest medical advances safely
and quickly. From speeding up access to life-saving vaccines to
setting high safety standards for new cancer tests, their work is
helping the NHS focus on earlier diagnosis and prevention. It was
fantastic to see first-hand how their expertise is driving
innovation, protecting patients, and strengthening our healthcare
system.
“British Science Week is a great time to celebrate their
achievements and the UK's world-leading expertise in medical
innovation.”
June Raine, MHRA Chief Executive, said:
“The MHRA plays a vital role in making the UK a science
superpower, working closely with the NHS and life sciences sector
to bring innovations to patients faster while maintaining public
trust in their safety.
“We were delighted to welcome Minister Smyth and showcase how our
expertise makes sure that scientific breakthroughs translate into
real benefits for patients. Our work ensures the NHS can access
cutting-edge medicines while upholding the highest safety
standards.”
Professor Anthony Harnden, MHRA Chair, said:
“Science and regulation go hand in hand in improving patient care
and patient safety. Today's visit was a great opportunity to
highlight how the MHRA's work supports the NHS and the people it
serves.
“It's important to recognise the scientists working behind the
scenes to protect patients and support NHS staff. Their expertise
gives healthcare professionals confidence that the treatments
they use work and are acceptably safe.”
